The stock's rise snapped a three-day losing streak.

The global cannabis and hemp market is experiencing dynamic changes driven by several factors. Growing consumer awareness about the therapeutic benefits ...

During the past five years, the reality of the cannabis industry has not lived up to the hype that accompanied Canada's ...

Tilray Medical, a division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), proudly announces that its German subsidiary, Tilray Deutschland GmbH, has secured a tender to supply Luxembourg with its ...

Philip Morris Intl. expands into cannabis via Avicanna partnership, focusing on medical research and innovation: How this move aligns with its long-term strategy.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Pallas Capital Advisors LLC increased its holdings in shares of Tilray Inc (NASDAQ:TLRY – Free Report) by 59.4% during the fourth quarter, according to its most recent 13F filing with the Securities ...

Tilray's major story during the year was its concentrated attempts to diversify away from marijuana, which is hardly a ringing endorsement of its efforts with the core products. The company spent ...

Tilray hopes that with legalization, it could export medical marijuana to the U.S. and capitalize on its infused beverage business. Despite delays in cannabis legalization efforts in the U.S., Tilray ...

Tilray Brands, Inc. (NASDAQ:TLRY) Q2 2025 Earnings Call Transcript January 9, 2025 Operator: Thank you for joining us for today's conference call to discuss Tilray Brands' financial results for ...